Insmed | Lånekapital



Loan Capital Endring Dato
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Cytokinetics USD 645.6M 1.1M 2024-12
DBV Technologies USD 0 0 2024-09
Dynavax Technologies USD 223.85M 293K 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
Insmed USD 1.13B 147.77M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Insmed Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.